MagPro R30

The MagPro R30

The MagPro R30 is our most popular TMS device and is favoured by both private and NHS clinics across the United Kingdom. It has an advanced high performance magnetic stimulator designed for clinical use. Clinicians report that the Super Flex arm allows ease of use and accurate coil positioning. The cooled coil ensures patient safety and comfort.  The MagPro R30 performs repetitive Transcranial Magnetic Stimulation (rTMS) and runs many complex protocols successively (up to 20,000 pulses).

The MagVita range of magnetic stimulators are the only TMS devices available in the UK that are CE approved for clinical use for the treatment of depression. - “treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from two prior antidepressant medications, at or above the minimal effective dose and duration in the current episode"

Applications
  • Examination of the physiology of the motor pathways in the central and peripheral nervous system
  • Is often used within Transcranial Magnetic Stimulation (TMS) and repetitive Transcranial Magnetic Stimulation (rTMS) research
Features
  • Biphasic waveform.
  • Stimulation rates up to 30 pulses per second.
  • 60 pps option available.
  • System operation control via a built-in computer, eliminating the need for an external computer to set up and control the timing of stimulus sequences.
  • Flexible protocol storage.
  • User friendly software.
  • Quick protocol set-up and storage.
  • Easily connected to external equipment (like EMG system) via the In/Out triggers.
  • Reporting functionality.

For more information about TMS for your hospital or clinic please fill out the contact form below or email tms@ectron.co.uk


In December 2015, the National Institute for Health and Care Excellence (NICE) approved rTMS (Repetitive Transcranial Magnetic Stimulation) as an effective and safe method of treating depression for patients in the UK. Repetitive Transcranial Magnetic Stimulation (rTMS) is a treatment which uses pulsing magnetic fields to activate brain centers associated with mood. The treatment has a number of advantages over traditional medication as it is non-invasive. It does not involve surgery, anesthesia or sedation and it does not have the side effects associated with antidepressants. rTMS has also been shown effective in treating migraine, post-natal depression and pain.

The evidence on repetitive transcranial magnetic stimulation for depression shows no major safety concerns [...] repetitive transcranial magnetic stimulation for depression may be used with normal arrangements for clinical governance and audit.”

To read the NICE Guidelines in full click here

Contact Us

Share by: